Association between IgG2 and IgG3 subclass responses to toxin A and recurrent Clostridium difficile-associated disease

被引:41
作者
Katchar, Kianoosh
Taylor, Claribel P.
Tummala, Sanjeev
Chen, Xinhua
Sheikh, Javed
Kelly, Ciaran P.
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Gastroenterol, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Infect Dis, Boston, MA 02215 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.cgh.2007.02.025
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Individuals who mount a significant serum immunoglobulin (Ig)G response to toxin A are protected against recurrent Clostridium difficile-associated disease (CDAD). We investigated whether humoral immune deficiencies and/or specific IgG subclass responses are associated with recurrent CDAD. Methods: We compared the clinical characteristics and humoral immune responses of 13 patients with recurrent CDAD with 13 matched controls with a single CDAD episode. We measured the serum IgG titers to tetanus and diphtheria toxoids, as well as total and toxin A- and toxin B-specific serum IgG, IgA, and IgG subclass concentrations. Results: There were no differences between the single and recurrent CDAD subjects in terms of age, sex, ethnicity, or other potential confounding variables. The total duration of diarrhea in patients with recurrent CDAD was greater (median, 62 vs 17 days; P = .005). IgG titers to tetanus and diphtheria toxoids, total IgG, and IgG subclass levels were similar in both groups. The total IgA was somewhat lower in those with recurrent CDAD (204 vs 254 mg/dL; P = .05). IgA, IgG, IgG1, and IgG4 anti-toxin A and anti-toxin B levels were similar in both groups. However, IgG2 and IgG3 anti-toxin A levels were significantly lower in the recurrent group (P = .01 and .001, respectively). Conclusions: subjects with recurrent CDAD did not show evidence of widespread humoral immune deficiency or of IgG subclass deficiency. Their low serum IgG anti-toxin A concentrations reflected selectively reduced IgG2 and IgG3 subclass responses. Measurement of specific IgG2/3 anti-toxin A may be useful in selecting patients for treatment with agents to prevent recurrent CDAD.
引用
收藏
页码:707 / 713
页数:7
相关论文
共 47 条
[1]   Rifalazil treats and prevents relapse of Clostridium difficile-associated diarrhea in hamsters [J].
Anton, PM ;
O'Brien, M ;
Kokkotou, E ;
Eisenstein, B ;
Michaelis, A ;
Rothstein, D ;
Paraschos, S ;
Kelly, CP ;
Pothoulakis, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) :3975-3979
[2]  
Bienvenu J, 1995, ANN BIOL CLIN-PARIS, V53, P499
[3]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[4]  
Clark MR, 1997, CHEM IMMUNOL, V65, P88
[5]  
Dati F, 1996, EUR J CLIN CHEM CLIN, V34, P517
[6]   Risk factors for early recurrent Clostridium difficile -: Associated diarrhea [J].
Do, AN ;
Fridkin, SK ;
Yechouron, A ;
Banerjee, SN ;
Killgore, GE ;
Bourgault, AM ;
Jolivet, M ;
Jarvis, WR .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :954-959
[7]  
Fekety R, 1997, AM J GASTROENTEROL, V92, P739
[8]   Recurrent Clostridium difficile diarrhea: Characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial [J].
Fekety, R ;
McFarland, LV ;
Surawicz, CM ;
Greenberg, RN ;
Elmer, GW ;
Mulligan, ME .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (03) :324-333
[9]  
FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511
[10]  
Hafner G, 1995, CLIN LAB, V41, P743